(SHOT) Safety Shot - Ratings and Ratios
Functional Beverage, Wellness Shot, Blood Alcohol
SHOT EPS (Earnings per Share)
SHOT Revenue
Description: SHOT Safety Shot
Safety Shot Inc (NASDAQ:SHOT) is a US-based company operating in the Personal Care Products sub-industry. The companys stock is currently trading at $0.65, with a market capitalization of $164.21M USD. Given its market cap, SHOT can be classified as a small-cap stock, which often comes with higher volatility and potential for growth.
The absence of a P/E ratio and Forward P/E ratio suggests that the company is currently not profitable, which is not uncommon for growth-stage companies. The lack of Return on Equity (RoE) further indicates that the companys profitability is not a key driver at this stage. Investors should focus on other key performance indicators (KPIs) such as revenue growth rate, customer acquisition costs, and product development pipeline to gauge the companys potential.
As a player in the Personal Care Products industry, SHOTs performance is likely influenced by broader market trends, including consumer demand for health and wellness products. Key economic drivers for the industry include demographic shifts, such as an aging population and increasing health consciousness among younger consumers. The companys ability to innovate and adapt to changing consumer preferences will be crucial to its success.
To evaluate SHOTs potential, investors should closely monitor its revenue growth, product development progress, and marketing efforts. A thorough analysis of the companys management team, their experience in the industry, and their strategy for driving growth will also be essential. Additionally, keeping an eye on the overall market sentiment and trends in the Personal Care Products industry will help investors make informed decisions.
SHOT Stock Overview
| Market Cap in USD | 70m |
| Sub-Industry | Personal Care Products |
| IPO / Inception | 2023-09-15 |
SHOT Stock Ratings
| Growth Rating | -74.0% |
| Fundamental | 33.7% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -59.1% |
| Analyst Rating | - |
SHOT Dividends
Currently no dividends paidSHOT Growth Ratios
| Growth Correlation 3m | 73.4% |
| Growth Correlation 12m | -70.4% |
| Growth Correlation 5y | -55.6% |
| CAGR 5y | -42.30% |
| CAGR/Max DD 5y | -0.44 |
| Sharpe Ratio 12m | -1.46 |
| Alpha | -71.11 |
| Beta | 0.884 |
| Volatility | 109.22% |
| Current Volume | 3070.4k |
| Average Volume 20d | 4826.4k |
| Stop Loss | 0.3 (-30.2%) |
| Signal | 1.06 |
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income (-17.4m TTM) > 0 and > 6% of Revenue (6% = 22.8k TTM) |
| FCFTA -0.46 (>2.0%) and ΔFCFTA 49.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 794.9% (prev 172.1%; Δ 622.8pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.32 (>3.0%) and CFO -13.3m > Net Income -17.4m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.16 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (150.2m) change vs 12m ago 190.4% (target <= -2.0% for YES) |
| Gross Margin -174.9% (prev -147.0%; Δ -27.92pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1.44% (prev 14.01%; Δ -12.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -43.89 (EBITDA TTM -15.7m / Interest Expense TTM 366.7k) >= 6 (WARN >= 3) |
Altman Z'' -17.87
| (A) 0.07 = (Total Current Assets 21.9m - Total Current Liabilities 18.9m) / Total Assets 42.1m |
| (B) -2.55 = Retained Earnings (Balance) -107.3m / Total Assets 42.1m |
| warn (B) unusual magnitude: -2.55 — check mapping/units |
| (C) -0.61 = EBIT TTM -16.1m / Avg Total Assets 26.4m |
| (D) -5.65 = Book Value of Equity -107.2m / Total Liabilities 19.0m |
| Total Rating: -17.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 33.71
| 1. Piotroski 0.0pt = -5.0 |
| 2. FCF Yield -31.15% = -5.0 |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.45 = 2.40 |
| 5. Debt/Ebitda -0.67 = -2.50 |
| 7. RoE -260.4% = -2.50 |
| 8. Rev. Trend -86.04% = -4.30 |
| 9. Rev. CAGR -72.53% = -2.50 |
| 10. EPS Trend 24.52% = 0.61 |
| 11. EPS CAGR 46.18% = 2.50 |
What is the price of SHOT shares?
Over the past week, the price has changed by -11.53%, over one month by -36.29%, over three months by +49.68% and over the past year by -52.14%.
Is Safety Shot a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SHOT is around 0.31 USD . This means that SHOT is currently overvalued and has a potential downside of -27.91%.
Is SHOT a buy, sell or hold?
What are the forecasts/targets for the SHOT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.3 | -20.9% |
Last update: 2025-08-25 04:46
SHOT Fundamental Data Overview
CCE Cash And Equivalents = 18.7m USD (Cash And Short Term Investments, last quarter)
P/S = 153.2533
P/B = 3.0212
Beta = 1.742
Revenue TTM = 379.4k USD
EBIT TTM = -16.1m USD
EBITDA TTM = -15.7m USD
Long Term Debt = 52.2k USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 10.5m USD (from shortTermDebt, last quarter)
Debt = 10.5m USD (Calculated: Short Term 10.5m + Long Term 52.2k)
Net Debt = 10.0m USD (from netDebt column, last quarter)
Enterprise Value = 61.5m USD (69.8m + Debt 10.5m - CCE 18.7m)
Interest Coverage Ratio = -43.89 (Ebit TTM -16.1m / Interest Expense TTM 366.7k)
FCF Yield = -31.15% (FCF TTM -19.2m / Enterprise Value 61.5m)
FCF Margin = -5053 % (FCF TTM -19.2m / Revenue TTM 379.4k)
Net Margin = -4589 % (Net Income TTM -17.4m / Revenue TTM 379.4k)
Gross Margin = -174.9% ((Revenue TTM 379.4k - Cost of Revenue TTM 1.04m) / Revenue TTM)
Tobins Q-Ratio = -0.57 (set to none) (Enterprise Value 61.5m / Book Value Of Equity -107.2m)
Interest Expense / Debt = 1.14% (Interest Expense 119.7k / Debt 10.5m)
Taxrate = 21.0% (US default)
NOPAT = -16.1m (EBIT -16.1m, no tax applied on loss)
Current Ratio = 1.16 (Total Current Assets 21.9m / Total Current Liabilities 18.9m)
Debt / Equity = 0.45 (Debt 10.5m / last Quarter total Stockholder Equity 23.1m)
Debt / EBITDA = -0.67 (Net Debt 10.0m / EBITDA -15.7m)
Debt / FCF = -0.55 (Debt 10.5m / FCF TTM -19.2m)
Total Stockholder Equity = 6.69m (last 4 quarters mean)
RoA = -41.39% (Net Income -17.4m, Total Assets 42.1m )
RoE = -260.4% (Net Income TTM -17.4m / Total Stockholder Equity 6.69m)
RoCE = -238.8% (set to none) (Ebit -16.1m / (Equity 6.69m + L.T.Debt 52.2k))
RoIC = -135.0% (set to none) (NOPAT -16.1m / Invested Capital 11.9m)
WACC = 8.17% (E(69.8m)/V(80.3m) * Re(9.27%)) + (D(10.5m)/V(80.3m) * Rd(1.14%) * (1-Tc(0.21)))
Shares Correlation 5-Years: 100.0 | Cagr: 66.66%
Discount Rate = 9.27% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -19.2m)
Revenue Correlation: -86.04 | Revenue CAGR: -72.53%
Rev Growth-of-Growth: 7.82
EPS Correlation: 24.52 | EPS CAGR: 46.18%
EPS Growth-of-Growth: 132.7
Additional Sources for SHOT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle